or Try an Advanced Search...

    Hematological Malignancies Stocks List

    Symbol Grade Name % Change
    TGTX B TG Therapeutics, Inc. 1.51
    CNTA B Centessa Pharmaceuticals plc -6.32
    ABBV D AbbVie Inc. 3.04
    CERO D CERo Therapeutics Holdings, Inc. -12.02
    PSTX D Poseida Therapeutics, Inc. 0.74
    MRKR D Marker Therapeutics, Inc. 5.02
    SNDX F Syndax Pharmaceuticals, Inc. 3.14
    ALRN F Aileron Therapeutics, Inc. -4.26
    ADAP F Adaptimmune Therapeutics plc 3.93
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Other
    Related Stock Lists: Cancer Solid Tumors Biopharmaceutical Immunotherapy Lymphoma Medicine Cancer Immunotherapy Cancer Treatment Clinical Medicine Immune System Treatment Of Cancer Tumor Virotherapy Adoptive Cell Transfer Cell Therapy Lung Cancer Non Small Cell Lung Cancer Oncogenes Ovarian Cancer Peptides

    Related ETFs - A few ETFs which own one or more of the above listed Hematological Malignancies stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.31
    MEDX F Horizon Kinetics Medical ETF 7.81
    GRID C First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 7.75
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 7.25
    View all Hematological Malignancies ETFs...
    Compare ETFs
    Compare BOTZ to GRID Compare HDLB to FTXH Compare MEDX to GRID

        Hematological Malignancies Stocks Recent News

        Date Stock Title
        Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
        Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
        Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
        Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
        Nov 21 TGTX TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
        Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
        Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 19 ABBV Where Will AbbVie Be in 5 Years?
        Nov 19 ABBV RVPH: Year-End OLE Update
        Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
        Nov 18 ABBV AbbVie snaps eight straight sessions of losses
        Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
        Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
        Nov 18 SNDX Syndax secures FDA OK for new kind of leukemia drug
        Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
        Nov 18 ABBV Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
        Nov 18 SNDX FDA approves Syndax’s Revuforj to treat leukaemia
        Nov 18 ABBV AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
        Related Industries: Biotechnology Drug Manufacturers - Major Other
        Related Stock Lists: Cancer Solid Tumors Biopharmaceutical Immunotherapy Lymphoma Medicine Cancer Immunotherapy Cancer Treatment Clinical Medicine Immune System Treatment Of Cancer Tumor Virotherapy Adoptive Cell Transfer Cell Therapy Lung Cancer Non Small Cell Lung Cancer Oncogenes Ovarian Cancer Peptides
        Hematological Malignancies

        Hematological malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematological malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for these cancers may include chemotherapy, radiation therapy, and/or stem cell transplantation.

        Browse All Tags